CGOC Announces Investment in Cannabis Healthcare Technology Leader Sail

Published: July 11, 2018

CGOC Announces Investment in Cannabis Healthcare Technology Leader Sail

Cannabis Growth Opportunity Corporation announced an investment in Sail Cannabis (Sail), a secure cloud-based cannabis healthcare decision making platform serving clinicians and patients. The deal demonstrates CGOC’s approach to leveraging its early mover advantage to access investments in high growth global companies.

Sail is an established healthcare technology company with a solid international presence, proven revenue model and positive cash flow from operations. The Sail platform offers knowledge translation and evidence-based data delivered through technology to support decisions at the point of care. Operating in over 14 markets across the globe, Sail has supported over 250,000 patients in their healthcare journeys with cannabis to date. The company plans to expand into Australia, Germany, Columbia and others in the next two years.

“We aim to give our shareholders the one-of-a-kind expertise and focus needed to grow investments in this unique market and this unique deal is an example of funding a private company poised to lead in its category,” said Jamie Blundell, President and COO of CGOC. “As more and more clinicians and patients learn about the medicinal and pharmaceutical benefits of cannabis, we expect Sail’s platform to provide the much-needed education and information to help them make informed decisions on qualification, dosing and prescriptions.”

CGOC invested $400,000 for 176,000 common share units of Sail.

Pradyum Sekar, Sail’s CEO and Co-Founder continued, “our goal is to break down the barriers between patients and the doctors who are willing to help them by providing access to educated physicians, education centers, and data support tools that can help patients make more informed decisions. Partners like CGOC are pivotal in our ability to help meet this increasing need around the world.”